SAN FRANCISCO, March 11 VIA Pharmaceuticals(Nasdaq: VIAP), a biotechnology company focused on the development ofcompounds for the treatment of cardiovascular disease, announced today thatLawrence Cohen PhD, chief executive officer, and James G. Stewart, senior vicepresident and chief financial officer, will present a company update at the2008 Cowen and Company 28th Annual Health Care Conference on Tuesday, March18, 2008 at 1:40 p.m. ET at the Boston Copley Marriott Place Hotel in Boston.
Interested parties may access a live audio webcast of the presentationfrom the investor section of the VIA website, www.viapharmaceuticals.com. Areplay of the presentation will be archived on the site for at least one weekfollowing the presentation.
About VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. is a biotechnology company focused on thedevelopment of compounds for the treatment of cardiovascular disease. VIA isbuilding a pipeline of small-molecule drugs that target a significant unmetmedical need: reducing inflammation in the blood vessel wall, which is anunderlying cause of atherosclerosis and its complications, including heartattack and stroke. The company's lead drug candidate, VIA-2291, is inmultiple Phase 2 clinical studies in patients with cardiovascular disease. Formore information, visit: www.viapharmaceuticals.com.
SOURCE VIA Pharmaceuticals